Fortis Life Sciences LLC has purchased Toronto-based International Point of Care Inc. (IPOC). Neither company disclosed the deal's financial terms.

Fortis Life Sciences LLC已购买多伦多国际护理点公司（IPOC）。这两家公司都没有披露该交易的财务条款。

IPOC develops and manufactures key components used in diagnostics, including lyophilized reagents, membranes, recombinant proteins, and controls. With this acquisition, Fortis can provide its customers with a customizable, end-to-end solution to advance their immunodiagnostic and molecular diagnostic products.

IPOC开发和制造用于诊断的关键组件，包括冻干试剂，膜，重组蛋白和对照。通过此次收购，Fortis可以为客户提供可定制的端到端解决方案，以推进其免疫诊断和分子诊断产品。

IPOC’s recently expanded 36,000-square-foot facility is Fortis’ third GMP and ISO 13485 compliant manufacturing site in North America. .

IPOC最近扩大了36000平方英尺的设施，是Fortis在北美的第三个符合GMP和ISO 13485标准的生产基地。。.

“Diagnostics and life sciences companies want a partner that can custom-design and validate reagents for their applications; control quality and cost with vertically integrated in-house manufacturing; and help them get their products to market faster,” Fortis Chief Business Officer Fred Pettijohn said.

Fortis首席商务官Fred Pettijohn说：“诊断和生命科学公司希望能够为其应用定制设计和验证试剂的合作伙伴；通过垂直整合的内部制造来控制质量和成本；并帮助他们更快地将产品推向市场。

“IPOC perfectly complements our existing capabilities, and we are pleased to introduce our expanded solution to the market.” .

“IPOC完美地补充了我们现有的功能，我们很高兴将我们扩展的解决方案引入市场。”。.

“We are excited to join Fortis and offer our customers a complete suite of materials and services,” IPOC CEO David Ray added. “Our combined expertise fully supports the diagnostic industry’s advances in ultra-high-sensitivity, point-of-care, and multiplexing applications as well as in novel technologies such as quantitative lateral flow, isothermal amplification, and CRISPR-based diagnostics.” .

IPOC首席执行官David Ray补充说：“我们很高兴加入Fortis并为客户提供全套材料和服务。”。“我们的综合专业知识充分支持诊断行业在超高灵敏度，即时护理和多路复用应用以及定量横向流动，等温扩增和基于CRISPR的诊断等新技术方面的进步。”。.

IPOC specializes in developing and manufacturing diagnostic components. IPOC serves many of the leading global diagnostic companies enabling the commercialization of new immunodiagnostic and molecular diagnostic technologies.

IPOC专门开发和制造诊断组件。IPOC为许多领先的全球诊断公司提供服务，使新的免疫诊断和分子诊断技术得以商业化。

Fortis partners with diagnostics and life sciences companies to custom design, validate, and manufacture proprietary solutions to solve their most difficult development problems. Fortis’ tailored approach and end-to-end capabilities accelerate the work of its customers as they bring the next generation of medicines and diagnostics to market.

Fortis与诊断和生命科学公司合作，定制设计，验证和制造专有解决方案，以解决其最困难的开发问题。Fortis量身定制的方法和端到端功能加速了客户的工作，因为他们将下一代药品和诊断推向市场。

Fortis serves a global customer base and has offices across the world including four R&D sites and three GMP and ISO 13485 compliant manufacturing facilities in North America.  .

Fortis服务于全球客户群，在世界各地设有办事处，包括四个研发站点和三个符合GMP和ISO 13485标准的北美制造工厂。  .